CIVIN; Curt I.

Patent Applications and Registrations

Patent applications and USPTO patent grants for CIVIN; Curt I..The latest application filed is for "high efficiency microfluidic purification of stem cells to improve transplants".

Company Profile

1.12.14

CIVIN; Curt I. - Baltimore MD
Civin; Curt I - Towson MD
Civin; Curt I. - Towson MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
High Efficiency Microfluidic Purification Of Stem Cells To Improve Transplants App 20210395682 - CIVIN; Curt I. ; et al.	2021-12-23
High efficiency microfluidic purification of stem cells to improve transplants Grant 11,142,746 - Civin , et al. October 12, 2	2021-10-12
Combinations Of Artemisinins, Bcl-2 Inhibitors, And Kinase Inhibitors For Cancer Treatment App 20200129470 - Civin; Curt I. ; et al.	2020-04-30
Methods and devices for high throughput purification Grant 10,324,011 - D'Silva , et al.	2019-06-18
Microfluidic Processing of Leukocytes for Molecular Diagnostic Testing App 20170333900 - Grisham; Michael ; et al.	2017-11-23
Methods And Systems For Processing Particles App 20170209864 - GRISHAM; Michael ; et al.	2017-07-27
High Efficiency Microfluidic Purification Of Stem Cells To Improve Transplants App 20160168539 - CIVIN; Curt I. ; et al.	2016-06-16
Methods And Devices For High Throughput Purification App 20160139012 - D'SILVA; Joseph ; et al.	2016-05-19
On-chip Microfluidic Processing Of Particles App 20160047735 - GRISHAM; Michael ; et al.	2016-02-18
High Efficiency Microfluidic Purification Of Stem Cells To Improve Transplants App 20150064153 - Civin; Curt I. ; et al.	2015-03-05
Microfluidic Processing Of Leukocytes For Molecular Diagnostic Testing App 20140342375 - Grisham; Michael ; et al.	2014-11-20
Therapeutic and diagnostic applications of genes differentially expressed in lympho-hematopoietic stem cells Grant 7,799,528 - Civin , et al. September 21, 2	2010-09-21
Modulation of systemic immune responses by transplantation of hematopoietic stem cells transduced with genes encoding antigens and antigen presenting cell regulatory molecules Grant 7,767,202 - Pardoll , et al. August 3, 2	2010-08-03
Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof App 20100184032 - Georgantas; Robert ; et al.	2010-07-22
Therapeutic and diagnostic applications of genes differentially expressed in lympho-hematopoietic stem cells App 20070036765 - Civin; Curt I. ; et al.	2007-02-15
Modulation of systemic immune responses by transplantation of hematopoietic stem cells transduced with genes encoding antigens and antigen presenting cell regulatory molecules App 20040142468 - Pardoll, Drew M ; et al.	2004-07-22
Fas ligand expressing hematopoietic cells for transplantation App 20040131599 - Civin, Curt I ; et al.	2004-07-08
Protein tyrosine kinase, JAK3 Grant 5,916,792 - Civin , et al. June 29, 1	1999-06-29
Nucleic Acid Encoding novel protein tyrosine kinase Grant 5,705,625 - Civin , et al. January 6, 1	1998-01-06
Method to determine the composition of bone marrow samples Grant 5,137,809 - Loken , et al. August 11, 1	1992-08-11
Human stem cells and monoclonal antibodies Grant 5,130,144 - Civin July 14, 1	1992-07-14
Release of cells from affinity matrices Grant 5,081,030 - Civin January 14, 1	1992-01-14
Human stem cells and monoclonal antibodies Grant 5,035,994 - Civin July 30, 1	1991-07-30
Human stem cells and monoclonal antibodies Grant 4,965,204 - Civin October 23, 1	1990-10-23
Human stem cells Grant 4,714,680 - Civin December 22, 1	1987-12-22

Company Registrations

NCAGE Code	448R3	CIVIN CURT I
CAGE Code	448R3	CIVIN, CURT I

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.